Susquehanna International Group
GMED icon

Susquehanna International Group’s Globus Medical GMED Stock Holding History

Susquehanna International Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.09M Sell
35,900
-20,500
-36% -$1.84M ﹤0.01% 5215
2025
Q4 		$4.92M Buy
56,400
+48,900
+652% +$3.71M ﹤0.01% 4044
2025
Q3 		$430K Sell
7,500
-100
-1% -$5.76K ﹤0.01% 9312
2025
Q2 		$449K Sell
7,600
-8,900
-54% -$575K ﹤0.01% 9429
2025
Q1 		$1.21M Sell
16,500
-38,600
-70% -$3.19M ﹤0.01% 6786
2024
Q4 		$4.56M Buy
55,100
+41,600
+308% +$3.28M ﹤0.01% 3744
2024
Q3 		$966K Sell
13,500
-5,600
-29% -$395K ﹤0.01% 6864
2024
Q2 		$1.31M Buy
19,100
+200
+1% +$11.9K ﹤0.01% 5962
2024
Q1 		$1.01M Sell
18,900
-15,700
-45% -$844K ﹤0.01% 6890
2023
Q4 		$1.84M Sell
34,600
-30,100
-47% -$1.47M ﹤0.01% 5541
2023
Q3 		$3.21M Buy
64,700
+60,400
+1,405% +$3.38M ﹤0.01% 4261
2023
Q2 		$256K Sell
4,300
-33,000
-88% -$1.88M ﹤0.01% 9767
2023
Q1 		$2.11M Buy
37,300
+34,600
+1,281% +$2.22M ﹤0.01% 5011
2022
Q4 		$201K Sell
2,700
-5,700
-68% -$388K ﹤0.01% 10124
2022
Q3 		$500K Buy
8,400
+2,300
+38% +$139K ﹤0.01% 8488
2022
Q2 		$342K Buy
6,100
+100
+2% +$6.57K ﹤0.01% 9218
2022
Q1 		$443K Sell
6,000
-16,000
-73% -$1.11M ﹤0.01% 9281
2021
Q4 		$1.59M Buy
22,000
+6,900
+46% +$501K ﹤0.01% 6072
2021
Q3 		$1.16M Sell
15,100
-5,200
-26% -$418K ﹤0.01% 7188
2021
Q2 		$1.57M Sell
20,300
-5,300
-21% -$377K ﹤0.01% 6509
2021
Q1 		$1.58M Buy
25,600
+8,100
+46% +$513K ﹤0.01% 6495
2020
Q4 		$1.14M Sell
17,500
-96,200
-85% -$5.53M ﹤0.01% 6410
2020
Q3 		$5.63M Sell
113,700
-56,200
-33% -$2.9M ﹤0.01% 2898
2020
Q2 		$8.11M Buy
169,900
+74,700
+78% +$3.6M ﹤0.01% 2388
2020
Q1 		$4.05M Sell
95,200
-45,600
-32% -$2.25M ﹤0.01% 2851
2019
Q4 		$8.29M Buy
140,800
+87,700
+165% +$4.76M ﹤0.01% 2300
2019
Q3 		$2.71M Sell
53,100
-35,800
-40% -$1.71M ﹤0.01% 3664
2019
Q2 		$3.76M Buy
88,900
+16,600
+23% +$721K ﹤0.01% 3113
2019
Q1 		$3.57M Buy
72,300
+55,200
+323% +$2.5M ﹤0.01% 2896
2018
Q4 		$740K Sell
17,100
-112,400
-87% -$5.61M ﹤0.01% 5279
2018
Q3 		$7.35M Buy
129,500
+10,000
+8% +$526K ﹤0.01% 2239
2018
Q2 		$6.03M Buy
119,500
+79,600
+199% +$4.15M ﹤0.01% 2495
2018
Q1 		$1.99M Sell
39,900
-23,100
-37% -$1.09M ﹤0.01% 3922
2017
Q4 		$2.59M Buy
63,000
+39,500
+168% +$1.38M ﹤0.01% 3475
2017
Q3 		$698K Buy
+23,500
New +$718K ﹤0.01% 5944
2017
Q2 		– Sell
-21,100
Closed -$625K – 9400
2017
Q1 		$625K Buy
21,100
+6,800
+48% +$186K ﹤0.01% 6081
2016
Q4 		$355K Sell
14,300
-2,500
-15% -$56.8K ﹤0.01% 7648
2016
Q3 		$379K Sell
16,800
-78,800
-82% -$1.85M ﹤0.01% 6550
2016
Q2 		$2.28M Buy
95,600
+40,500
+74% +$971K ﹤0.01% 3357
2016
Q1 		$1.31M Buy
+55,100
New +$1.35M ﹤0.01% 4545
2015
Q3 		– Sell
-22,600
Closed -$580K – 9795
2015
Q2 		$580K Sell
22,600
-4,400
-16% -$111K ﹤0.01% 7326
2015
Q1 		$681K Sell
27,000
-11,500
-30% -$280K ﹤0.01% 6544
2014
Q4 		$915K Buy
38,500
+25,900
+206% +$573K ﹤0.01% 6047
2014
Q3 		$248K Buy
+12,600
New +$259K ﹤0.01% 8311

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's GMED Position: Q1 2026 in Review

Susquehanna International Group increased its Globus Medical (GMED) stake by 251% in Q1 2026, buying an estimated $975K and bringing the position to 15,203 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #7214.

Susquehanna International Group first reported a position in GMED in Q4 2013 and has held it in 35 quarters since. The position peaked at $16M in Q3 2023. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Susquehanna International Group held 15,203 shares of Globus Medical worth $1.31M as of Q1 2026.
  • Susquehanna International Group bought 10,868 Globus Medical shares in Q1 2026, an estimated $975K.
  • Globus Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7214 holding.
  • Susquehanna International Group first reported a position in Globus Medical in Q4 2013 and has held it in 35 quarters since.
  • Susquehanna International Group's Globus Medical position peaked at $16M in Q3 2023.
  • 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.